We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.


20 February 2004 By Robert Cyran

If Aventis is taken over by Sanofi, its shareholders will own 49% of share capital, but only 39% of the vote due to double voting. Eliminating the scheme would raise Sanofi s stock price, and make the bid more attractive.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)